CN112111512A - Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish - Google Patents

Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish Download PDF

Info

Publication number
CN112111512A
CN112111512A CN202010718925.5A CN202010718925A CN112111512A CN 112111512 A CN112111512 A CN 112111512A CN 202010718925 A CN202010718925 A CN 202010718925A CN 112111512 A CN112111512 A CN 112111512A
Authority
CN
China
Prior art keywords
kdrl
sequence
zebra fish
knock
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010718925.5A
Other languages
Chinese (zh)
Inventor
顾珊烨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Xinjia Pharmaceutical Technology Co Ltd
Original Assignee
Nanjing Xinjia Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Xinjia Pharmaceutical Technology Co Ltd filed Critical Nanjing Xinjia Pharmaceutical Technology Co Ltd
Priority to CN202010718925.5A priority Critical patent/CN112111512A/en
Publication of CN112111512A publication Critical patent/CN112111512A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K61/00Culture of aquatic animals
    • A01K61/10Culture of aquatic animals of fish
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276Knock-out vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/20Animal model comprising regulated expression system
    • A01K2217/206Animal model comprising tissue-specific expression system, e.g. tissue specific expression of transgene, of Cre recombinase
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/40Fish
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/106Plasmid DNA for vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/30Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a method for researching the growth of a kdrl (vegfr2) gene in blood vessels by conditional induction in zebra fish, which comprises the following steps: (1) preparing a kdrl conditional knockout strain by using non-homologous end joining; (2) crossing a transgenic line marked with vascular endothelial cells with a kdrl conditional knockout line to establish a double-transgenic line; (3) cre mRNA is injected into embryos generated by the double-transgenic line internal crossing to realize kdrl knockout, and the abnormality of blood vessel growth is observed and evaluated through fluorescence.

Description

Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish
Technical Field
The invention relates to the technical field of genetic engineering, in particular to a method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish.
Background
The zebrafish kdrl gene (vascular growth factor receptor 2, vegfr2, also known as flk1) is important for vascular development. Aiming at the kdrl gene, the promoter of the gene can be used for specifically marking the vascular endothelial cells at present, which indicates that the gene is specifically expressed in the vascular endothelial cells. The importance of kdrl on vascular growth was also shown by mutant line studies of this gene (see references 1 and 2).
At present, a method for researching the growth of blood vessels by conditionally inducing kdrl gene knockout in zebrafish is lacked.
Disclosure of Invention
The invention aims to provide a method for researching the growth of blood vessels by combining the operation of a kdrl gene with a transgenic line for marking vascular endothelial cells and realizing conditional induction of kdrl knockout in zebrafish.
The purpose of the invention is realized by the following technical scheme: the invention relates to a zebra fish strain with a krrl knockout conditional prepared by non-homologous end connection, which researches the growth and development of blood vessels in vivo by marking a transgenic strain of vascular endothelial cells and a Cre system, and comprises the following steps:
(1) searching two specific recognition sites of nuclease at two ends of the 12 th exon of the zebra fish kdrl, wherein the specific recognition sites are a sgRNA1 target spot and a sgRNA2 target spot;
(2) constructing a knock-in plasmid with non-homologous end connection, wherein the knock-in plasmid contains a nucleotide sequence of a left homologous arm and a nucleotide sequence of the left homologous arm, the left arm contains one nuclease recognition site sgRNA1, the right arm contains the other nuclease recognition site sgRNA2, an exogenous gene sequence needing to be replaced is contained between the left arm and the right arm, and the exogenous gene sequence comprises loxP sites on two sides of a 12 th exon and cardiac muscle cell marker red fluorescent protein capable of being used for screening; injecting a nuclease system into the fertilized eggs of the zebra fish by microinjection; culturing the injected fertilized eggs into fish, and confirming that the zebra fish is knocked out conditionally by kdrl through fluorescence and genotype identification;
(3) hybridizing a transgenic strain marked with zebra fish vascular endothelial cells with the conditional knockout strain, and obtaining a double-transgenic strain through fluorescence screening;
(4) cre mRNA was injected into embryos generated by the double transgenic introgression described above, and zebrafish embryos were used after 3 days to identify deletion of kdrl, overall phenotypic observation, and phenotypic observation of vascular growth.
Further, in step (1), the nucleases are CRIPSR nuclease and Cas9 nuclease.
Further, in step (2), the nuclease system includes Cas9 protein or mRNA producing Cas9 protein, sgRNA1 and sgRNA2, kdrl knock-in plasmids.
Further, in step (2), the target sequence of sgRNA1 is: gtaaacagtctgtgaacccc, respectively; the target sequence of sgRNA2 is: gtgagaggggtacagtacgg are provided.
Further, in the step (2), the nucleotide sequence of the left homology arm is shown in SEQ ID NO:1, and the nucleotide sequence of the right homology arm is shown in SEQ ID NO:1, and the sequence of the foreign gene needing to be replaced is shown as SEQ ID NO: 693-2576 in 1.
Further, in the step (2), constructing a left homologous arm and a right homologous arm of the knock-in plasmid connected with the non-homologous ends, taking a zebra fish genome as a template, and adding enzyme cutting sites and protective bases into a PCR primer for amplification to obtain the zebra fish genome; a sequence between two loxP sites of the fourth exon is amplified by taking a zebra fish genome as a template and a loxP-kdrl _ exon12-frt fusion sequence through a loxP and frt fusion sequence PCR primer, and the PCR primer is added with a restriction enzyme site and a protective base; the red fluorescent protein sequence can be marked by the screened cardiac muscle cells, the loxP-myl7-DsRed-pA-frt fusion sequence is obtained by amplifying the fusion sequence PCR primer of loxP and frt, and the PCR primer is added with the enzyme cutting site and the protective basic group.
Further, in step (2), the donor plasmid was knocked in and zebrafish zygotes were injected, and conditional knock-in strains that yielded tcf3a were selected.
Further, in the step (3), the zebra fish line for labeling the vascular endothelial cells is Tg (flk 1: EGFP).
Has the advantages that: the method allows in vivo and conditional investigation of vascular growth. According to the invention, the prepared kdrl conditional knockout zebra fish is combined with the transgenic zebra fish specifically labeled with vascular endothelial cells, so that the kdrl knockout after conditional induction can be well realized in vivo to study the vascular growth method.
The invention has the following advantages:
(1) the method provided by the invention is applied to research on the growth and development of zebra fish blood vessels, can induce the knockout of the kdrl gene at different times, can research the effect of kdrl in the growth and development of muscle blood vessels in different development stages, and is a latest method for applying an inducible gene knockout technology to the research on the zebra fish blood vessels.
(2) The invention utilizes zebra fish living model and observes the growth and development of the endothelial cells in the myoblood vessels by a fluorescent protein labeling method.
Drawings
For ease of illustration, the invention is described in detail by the following specific examples and figures:
FIG. 1 is a schematic diagram of the integration of a double loxP site mediated by non-homologous recombination into zebrafish kdrl gene according to the present invention;
the zebrafish kdrl gene plays an important role in the formation of the vascular network at an early developmental stage (ref.). sgRNA1 and sgRNA2 targets are indicated by red or blue arrows, respectively. In the kdrl conditioned donor (kdrl-loxP-exon12-frt-SM-frt-loxP), two loxP sites and homology arms (double-arrowed brown line) were added. The left and right arms were 686bps and 1297bps long, respectively. To reduce the effort of intensive screening for conditional alleles, a selectable marker (SM, 1.2kb) can express DsRed under the control of the myl7 promoter in the reverse direction of transcription compared to tcf3 a. SM also flanks the frt recombination site and can therefore be excised by Flp recombinase. Zebrafish kdrl has 30 exons and E12 (exon 12) contains 109 bps. After co-injection of the donor with sgRNA1, sgRNA2 and zCas9 mRNA, endogenous E12 was replaced at the kdrl site by kdrl-loxP-exon 12-frt-SM-frt-loxP. Black short arrows indicate primers used for validation (F1, R1, F2, R2).
FIG. 2 is a PCR and phenotypic characterization of kdrl conditional knockout lines of the invention after flp, Cre mRNA injection;
(C) in heterozygous embryos injected with flp mRNA at the single cell stage into kdrl conditional knockout lines, PCR at 3dpf identified deletion of SM. (D) No ("-Cre") or injection ("+ Cre") Cre mRNA into heterozygote Ki (kdrl) at the single cell stagef1) Progeny from the intercross, PCR at 3dpf, identified a deletion of kdrl exon 12. Red arrow indicates
Figure RE-GDA0002788380540000031
The other products of (A) are in principle derived from the original by Cre
Figure RE-GDA0002788380540000041
And (4) cutting off the fragment. (E and F)3dpf large double transgene [ Tg (kdrl: EGFP); ki (kdrl)fl/+)]Brightfield (top) and confocal (bottom) images of young fish produced by intercrossing. Cre mRNA injection, or not, at the single cell stage, indicates that Cre mRNA injection results in loss of cardiac DsRed expression (inset in E1) and vascular defects in the trunk (E2) and brain (E3). Scale bar: 250 μm (E1, F1), 100 μm (E2, E3, F2, F3).
Detailed Description
The present invention is further illustrated in detail by the following examples, but it should be noted that the scope of the present invention is not limited by these examples at all.
The invention relates to a zebra fish strain with a kdrl knockout conditional prepared by non-homologous end connection, which researches the growth and development of blood vessels in vivo by marking a transgenic strain of vascular endothelial cells and a Cre system, and comprises the following steps:
(1) searching two specific recognition sites of nuclease at two ends of the 12 th exon of the zebra fish kdrl, wherein the specific recognition sites are a sgRNA1 target spot and a sgRNA2 target spot; the nuclease is CRIPSR nuclease and Cas9 nuclease.
(2) Constructing a knock-in plasmid with non-homologous end connection, wherein the knock-in plasmid contains a nucleotide sequence of a left homologous arm and a nucleotide sequence of the left homologous arm, the left arm contains one nuclease recognition site sgRNA1, the right arm contains the other nuclease recognition site sgRNA2, an exogenous gene sequence needing to be replaced is contained between the left arm and the right arm, and the exogenous gene sequence comprises loxP sites on two sides of a 12 th exon and cardiac muscle cell marker red fluorescent protein capable of being used for screening; injecting a nuclease system into the fertilized eggs of the zebra fish by microinjection; culturing the injected fertilized eggs into fish, and confirming the kdrl conditional knockout zebra fish through fluorescence and genotype identification (see figure 1);
the nuclease system comprises Cas9 protein or mRNA for generating Cas9 protein, sgRNA1 and sgRNA2, and kdrl knock-in plasmids.
The target sequence of sgRNA1 is: gtaaacagtctgtgaacccc, respectively; the target sequence of sgRNA2 is: gtgagaggggtacagtacgg are provided.
The nucleotide sequence of the left homology arm is shown as SEQ ID NO:1, and the nucleotide sequence of the right homology arm is shown in SEQ ID NO:1, and the sequence of the foreign gene needing to be replaced is shown as SEQ ID NO: 693-2576 in 1.
Constructing a left homologous arm and a right homologous arm of a knock-in plasmid connected with a non-homologous end, taking a zebra fish genome as a template, and adding a restriction enzyme site and a protective base into a PCR primer for amplification to obtain the zebra fish genome; a sequence between two loxP sites of the fourth exon is amplified by taking a zebra fish genome as a template and a loxP-kdrl _ exon12-frt fusion sequence PCR primer, and the PCR primer is added with a restriction enzyme site and a protective base; the red fluorescent protein sequence can be marked by the screened cardiac muscle cells, the loxP-myl7-DsRed-pA-frt fusion sequence is obtained by amplifying the fusion sequence PCR primer of loxP and frt, and the PCR primer is added with the enzyme cutting site and the protective basic group.
The donor plasmid was knocked in and zebrafish zygotes were injected and screened for conditional knock-in lines to obtain tcf3 a.
(3) Hybridizing a transgenic strain marked with zebra fish vascular endothelial cells with the conditional knockout strain, and obtaining a double-transgenic strain through fluorescence screening;
(4) cre mRNA was injected into embryos generated by the above-described double transgenic introgression, and zebrafish embryos were used after 3 days to identify deletion of kdrl (see FIGS. 2C and 2D), observation of the overall phenotype, and observation of the phenotype of vascular growth (see FIGS. 2E and 2F).
The zebra fish product line for marking the vascular endothelial cells is Tg (flk 1: EGFP).
Example 1
In the embodiment, the main design idea is as follows:
1. designing specific guide RNA aiming at the sequences at both sides of the target segment of the target gene.
2. PDM-19T is used as a framework to construct donor plasmids. The plasmid comprises three parts: left arm sequence, exogenous sequence, and right arm sequence. The sequence of the left arm is the genomic sequence 5' upstream of the segment of interest and comprises the left guide RNA target sequence. The left arm sequence is followed by the exogenous sequence. Next is the right arm, the 3' downstream sequence of the right arm target segment, and contains the guide RNA target sequence on the right.
3. The above synthesized guide RNA and donor plasmid, together with optimized zebrafish Cas9 mRNA, were co-microinjected into one-cell stage zebrafish zygotes and further screened for conditional knockout lines.
4. Hybridizing a transgenic strain marked with the vascular endothelial cells of the zebra fish with the conditional strain, and screening the transgenic zebra fish specially by fluorescence;
5. the phenotype of zebrafish vascular growth and development was identified and analyzed by microinjection of Cre mRNA into embryos generated by double-heterozygous internal crossing of kdrl conditional knock-outs and Tg (flk 1: EGFP).
Materials and methods:
1. construction of knock-in Donor plasmid for loxP-kdrl _ exon12-frt-SM-frt-loxP
The genome of zebra fish and DsRed plasmid marking the heart of zebra fish are taken as templates, and loxP-kdrl _ exon12-frt-SM-frt-loxP fusion sequences are obtained by PCR primer amplification of the loxP and frt fusion sequences. Adding enzyme cutting sites and protecting bases into PCR primers.
LF:ctcggtacctcagtgataacaaggcctgt(SEQ ID NO:2)
LR:tatGAGCTCcagtttacttcctggggttc(SEQ ID NO:3)
MF:ctggagctcataacttcgtatagcatacattatacgaagttatataaatgggtatattgctcc(SEQ ID NO:4)
MR:taagcatgcgaagttcctatactttctagagaataggaacttccaatcaaatcaatcaaatca(SEQ ID NO:5)
SM-F:ttcgcatgcttaagatacattgatgagtt(SEQ ID NO:6)
SM-R: TATagatctGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCtcatccatccttttcatccc (SEQ ID NO:7)
RF: TTCagatctATAACTTCGTATAGCATACATTATACGAAGTTATtttcatagtaaaagtatgag (SEQ ID NO:8)
RR:caggtcgacatctcctgtcttcattttta(SEQ ID NO:9)
loxP is a sequence recognized by Cre recombinase, and a sequence between two loxP sites in the same orientation can be deleted by Cre recombinase.
The amplified sequences were ligated sequentially into pMD-19T vector (purchased from Takara) to form the final donor plasmid.
2. Synthesis of sgRNA and zCas9 mRNA
Plasmid pGH-T7-ZCAS9 expressing ZCAS9 was obtained from the university of Beijing, Life sciences college. The plasmid was linearized with Xba I endonuclease and purified by transcription with mMACHINE T7 Ultra kit (Ambion) to obtain ZCAS9 mRNA.
The DNA sequences used to prepare the different sgrnas are shown below:
kdrl sgRNA 1: gtaaacagtctgtgaacccc (SEQ ID NO:10) (reverse strand, on the antisense strand);
kdrl sgRNA 2: gtgagaggggtacagtacgg (SEQ ID NO:11) (forward strand, on the sense strand);
the above sgRNA sequences were cloned into BbsI sites of pT7-sgRNA plasmid (obtained from Life sciences of Beijing university) respectively, transcribed in vitro by MaxiScript T7 kit (Ambion), and used with mirVanaTMAnd recovering the miRNA Isolation Kit (Ambion) Kit to obtain the guide RNA.
3. Zebra fish strain and breeding
The adult zebra fish is cultured in an aquatic animal culture system of Beijing Aisheng company in an environment with the water temperature of 28 ℃, the pH value of 7-8 and the photoperiod of 14 hours light/10 hours dark. Embryos were raised in 10% Hank's solution. The solution composition was as follows (millimoles): 140NaCl, 5.4KCl, 0.25Na2HPO4,0.44KH2PO4,1.3CaCl2, 1.0MgSO4And 4.2NaHCO3(pH 7.2)。
4. Microinjection
zCas9 mRNA, sgRNA and donor plasmid were injected together by microinjection into one-cell stage zebrafish zygotes. Each fertilized egg was injected with 1nl of liquid. Containing 600 ng/. mu.l zcAS9 mRNA, 100 ng/. mu.l sgRNA, and 15 ng/. mu.l donor plasmid. The fertilized eggs can directly develop into the zebra fish under the in vitro culture condition (see 3. zebra fish feeding). The injection concentration of Cre mRNA was 100 ng/ul.
5. PCR validation of genomic substitutions
Extracting gene DNA of zebra fish embryo, identifying correct insertion and gene replacement by PCR method, using primers as follows:
kdrl-LF:TTGGCAGGGGTAAAGCACAG(SEQ ID NO:12);
DsRed-R:CCCACAACGAGGACTACACC(SEQ ID NO:13);
DsRed-F:CCCTTGGTCACCTTCAGCTT(SEQ ID NO:14);
kdrl-RR:AACGTGCCACTTGACATCCA(SEQ ID NO:15);
6. confocal imaging
Confocal imaging successive fluorescence pictures were taken in the Z-axis direction using FV1000 confocal microscope (Olympus, Japan) with 20-fold or 40-fold water scope (n.a., 0.80) in the form of optical sections. The resolution of all pictures is 1024 × 1024 or 800 × 600. The structural morphology was later reconstructed by ImageJ software (NIH).
The foregoing shows and describes the general principles, essential features, and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are described in the foregoing description only for the purpose of illustrating the principles of the present invention, but that various changes and modifications may be made therein without departing from the spirit and scope of the invention as defined by the appended claims, specification and equivalents thereof.
Sequence listing
<110> Nanjing and admire technology and technology Limited
<120> method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish
<130> 2020
<160> 15
<170> SIPOSequenceListing 1.0
<210> 1
<211> 6538
<212> DNA
<213> Artificial sequence (nucleotide sequence of left and right homology arms)
<400> 1
ggtacctcag tgataacaag gcctgtttaa aagggttgga tttgtttaga gcgaattcct 60
ttctgtcacc tcatataaat tttccagctc tgtgaacaac aggctggtat ggtccatctc 120
aaatggtgcc ttttaaccat agaatgagaa atggccactt aaagacaaag taggaaggtc 180
attctaaatt gctgacaagg tcatcagaga aatgattaga aaagcttgat gtactttaat 240
gtgtaatgtc attacaggtt gagcctggtg aacattgtgt tgatcaattg aatttcagac 300
caatatttca atgcctagtt aaaatagatt ggtaaggcaa atagatggaa acatgcctgc 360
tttctcatgt atatttttgt gcagtgtgcc aattaaaaaa atcggcttca tgtaagacta 420
aacaacgaca tgccattgca ctacatcagc tccacagatt tacattaacc aaactccaca 480
cctcatttca gtctgttcaa cagtataacg ttgtgtacaa gagaaattct aagctttgta 540
aaaaattctt ttgcattaaa tatgagtgtt gtacatcttt acaaactaaa acagaaaaac 600
aattaaaata cctgttgttc agagccaacg ctgtatttct tcagtttcaa ataagtctta 660
taaacagtct gtgaacccca ggaagtaaac tggagctcat aacttcgtat agcatacatt 720
atacgaagtt atataaatgg gtatattgct ccagaaatac acccagagtg tttcatacct 780
ttgatgtgac ggccaagaaa acagatgtag tttgaaactg aaaacagagc ccagtaatct 840
ggtctcgtgc caaaaacctg catcattatt atgtctactt aggctattaa tgagttccag 900
ttgaatggta acaatattaa gcctggcatt ttaaatgtgt atgaggaaat tacatgggac 960
gtggacatgc cttctgtgat ttatgagatg tgaaaagttg tgttattacg ggttaaagaa 1020
tattttgatt aacacttcta ataatctttt ctcatcctct tagactataa gtaccctggt 1080
ggtgaaaaca gctaatgtgt ctggggtata ctcctgtaca gcaaggaatg aacttggcaa 1140
ccggaccatg agaatccctt tttatgtgga tggtatgtta gtcattttat atgtactgaa 1200
cgttaatgtc acatgttatt tgtggttttg tggcatatag atggtctgat ttgattgatt 1260
tgattggaag ttcctattct ctagaaagta taggaacttc gcatgcttaa gatacattga 1320
tgagtttgga caaaccacaa ctagaatgca gtgaaaaaaa tgctttattt gtgaaatttg 1380
tgatgctatt gctttatttg taaccattat aagctgcaat aaacaagtta acaacaacaa 1440
ttgcattcat tttatgtttc aggttcaggg ggaggtgtgg gaggtttttt aaagcaagta 1500
aaacctctac aaatgtggta tggctgatta tgatctagag tcgcggccgc tacaggaaca 1560
ggtggtggcg gccctcggcg cgctcgtact gctccacgat ggtgtagtcc tcgttgtggg 1620
aggtgatgtc cagcttggag tccacgtagt agtagccggg cagctgcacg ggcttcttgg 1680
ccatatagat agacttgaac tccaccaggt agtggccgcc gtccttcagc ttcagggcct 1740
tgtggatctc gcccttcagc acgccgtcgc gggggtacag gcgctcggtg gaggcctccc 1800
agcccatagt cttcttctgc attacggggc cgtcggaggg gaagttcacg ccgatgaact 1860
tcaccttgta gatgaaggag ccgtcctgca gggaggagtc ctgggtcacg gtcaccacgc 1920
cgccgtcctc gaagttcatc acgcgctccc acttgaagcc ctcggggaag gacagcttct 1980
tgtagtcggg gatgtcggcg gggtgcttca cgtacacctt ggagccgtac tggaactggg 2040
gggacaggat gtcccaggcg aagggcaggg ggccgccctt ggtcaccttc agcttggcgg 2100
tctgggtgcc ctcgtagggg cggccctcgc cctcgccctc gatctcgaac tcgtggccgt 2160
tcacggagcc ctccatgcgc accttgaagc gcatgaactc cttgatgacg tcctcggagg 2220
aggccatacc ggttcactgt ctgctttgct gttggtctgg gctcctgggt cactgactta 2280
ctaatggagt ctttatgtat gaggactctt atcatttgtt cttctataaa ggtctgcagt 2340
gtttctgttc gtcccctaca tggacaccca gagcctccta aatacaggag ccctgataac 2400
tgcacaagtg ctcagattcc agcagggtgg aaaatgagat aaagtgtgca gatggggagg 2460
gggacgtgaa tgagagattt gagggatgaa aaggatggat gagaagttcc tattctctag 2520
aaagtatagg aacttcagat ctataacttc gtatagcata cattatacga agttattttc 2580
atagtaaaag tatgagaggg gtacagtacg gtggtcgaga gcatcttcat ccctttgaca 2640
gtacacttgt tgtaaattag tcacaacaca aacaagtaaa gaaacgcgca gcaaattgat 2700
cacaacactt gcaaatattc acgtaacaca acggaaatgt ttctagtgga ttaaaaaaca 2760
tgacggaccc tgctgagata tggatgtgtt attatgctgt gactgttgct cagtaaagtg 2820
attggtggtc tttgtttgta tctctcggcc accttcgtac agtggcgtag cggcaattgt 2880
aaaagtgggt gactgctgta tgtgacataa aggttaagca taatcatttg cttttttttt 2940
ttaaattaag gtataattcc ttaaaatatt gctgatcagt tcccaaacag tgccttaaaa 3000
tagtcagttc ccttttttat acaaatttca ctagttaggg catagcagta aatatttaaa 3060
agactaaaat tttataaagc atacttaggc aacaaacgac agcagaacct gatggacaaa 3120
tcttgaaaat tatttatggg gggcatgaca attataaggg ttggagaaca cgggtggaaa 3180
tattggagat aggtaaaaaa aaaaagtgct aacatgcaaa ctccacacag aaatgcccac 3240
tggtccagcc aggacttaaa ccgaagagct tctcactgtg tggcaacaac tgagccattg 3300
tgctgcccct ttattttcag atagaaaata aatatttgaa caattttctt gcaactttta 3360
tgtttatggt tgtcactata catgatctgt atgtcagcta ttctgaaaga aatgttttta 3420
tatatttaaa tgtatatttt gcatccttga ttgtttcagc tgttcagagc actatgtgtt 3480
ttattacatg gtgaattctg gctgacttct cgcctgtcaa cttaagcttg tgattgagca 3540
gtattggtgt taaaataaaa gttcctcact ctaggcaaaa acatgcaaat gtagttcctg 3600
ttcttctgct ccactctgga ttggactcag gcactaatat gccaactcct gttttaaaat 3660
gaatcacttt tatttgtcgc tgaccagggt caaatgtttc tgaaatgaga aacccattca 3720
cccagttatg taatgaagag tgtgtcggct gtcagacttt tcaaagctgc ttagattaga 3780
atgatgagaa aaaatgagct gcggtaaaca gcagccgtgg tttggagagg tgtaaaaaat 3840
gagaactgtg caataaaaat gaagacagga gatgtcgacc tgcaggcatg caagcttggc 3900
gtaatcatgg tcatagctgt ttcctgtgtg aaattgttat ccgctcacaa ttccacacaa 3960
catacgagcc ggaagcataa agtgtaaagc ctggggtgcc taatgagtga gctaactcac 4020
attaattgcg ttgcgctcac tgcccgcttt ccagtcggga aacctgtcgt gccagctgca 4080
ttaatgaatc ggccaacgcg cggggagagg cggtttgcgt attgggcgct cttccgcttc 4140
ctcgctcact gactcgctgc gctcggtcgt tcggctgcgg cgagcggtat cagctcactc 4200
aaaggcggta atacggttat ccacagaatc aggggataac gcaggaaaga acatgtgagc 4260
aaaaggccag caaaaggcca ggaaccgtaa aaaggccgcg ttgctggcgt ttttccatag 4320
gctccgcccc cctgacgagc atcacaaaaa tcgacgctca agtcagaggt ggcgaaaccc 4380
gacaggacta taaagatacc aggcgtttcc ccctggaagc tccctcgtgc gctctcctgt 4440
tccgaccctg ccgcttaccg gatacctgtc cgcctttctc ccttcgggaa gcgtggcgct 4500
ttctcatagc tcacgctgta ggtatctcag ttcggtgtag gtcgttcgct ccaagctggg 4560
ctgtgtgcac gaaccccccg ttcagcccga ccgctgcgcc ttatccggta actatcgtct 4620
tgagtccaac ccggtaagac acgacttatc gccactggca gcagccactg gtaacaggat 4680
tagcagagcg aggtatgtag gcggtgctac agagttcttg aagtggtggc ctaactacgg 4740
ctacactaga agaacagtat ttggtatctg cgctctgctg aagccagtta ccttcggaaa 4800
aagagttggt agctcttgat ccggcaaaca aaccaccgct ggtagcggtg gtttttttgt 4860
ttgcaagcag cagattacgc gcagaaaaaa aggatctcaa gaagatcctt tgatcttttc 4920
tacggggtct gacgctcagt ggaacgaaaa ctcacgttaa gggattttgg tcatgagatt 4980
atcaaaaagg atcttcacct agatcctttt aaattaaaaa tgaagtttta aatcaatcta 5040
aagtatatat gagtaaactt ggtctgacag ttaccaatgc ttaatcagtg aggcacctat 5100
ctcagcgatc tgtctatttc gttcatccat agttgcctga ctccccgtcg tgtagataac 5160
tacgatacgg gagggcttac catctggccc cagtgctgca atgataccgc gagacccacg 5220
ctcaccggct ccagatttat cagcaataaa ccagccagcc ggaagggccg agcgcagaag 5280
tggtcctgca actttatccg cctccatcca gtctattaat tgttgccggg aagctagagt 5340
aagtagttcg ccagttaata gtttgcgcaa cgttgttgcc attgctacag gcatcgtggt 5400
gtcacgctcg tcgtttggta tggcttcatt cagctccggt tcccaacgat caaggcgagt 5460
tacatgatcc cccatgttgt gcaaaaaagc ggttagctcc ttcggtcctc cgatcgttgt 5520
cagaagtaag ttggccgcag tgttatcact catggttatg gcagcactgc ataattctct 5580
tactgtcatg ccatccgtaa gatgcttttc tgtgactggt gagtactcaa ccaagtcatt 5640
ctgagaatag tgtatgcggc gaccgagttg ctcttgcccg gcgtcaatac gggataatac 5700
cgcgccacat agcagaactt taaaagtgct catcattgga aaacgttctt cggggcgaaa 5760
actctcaagg atcttaccgc tgttgagatc cagttcgatg taacccactc gtgcacccaa 5820
ctgatcttca gcatctttta ctttcaccag cgtttctggg tgagcaaaaa caggaaggca 5880
aaatgccgca aaaaagggaa taagggcgac acggaaatgt tgaatactca tactcttcct 5940
ttttcaatat tattgaagca tttatcaggg ttattgtctc atgagcggat acatatttga 6000
atgtatttag aaaaataaac aaataggggt tccgcgcaca tttccccgaa aagtgccacc 6060
tgacgtctaa gaaaccatta ttatcatgac attaacctat aaaaataggc gtatcacgag 6120
gccctttcgt ctcgcgcgtt tcggtgatga cggtgaaaac ctctgacaca tgcagctccc 6180
ggagacggtc acagcttgtc tgtaagcgga tgccgggagc agacaagccc gtcagggcgc 6240
gtcagcgggt gttggcgggt gtcggggctg gcttaactat gcggcatcag agcagattgt 6300
actgagagtg caccatatgc ggtgtgaaat accgcacaga tgcgtaagga gaaaataccg 6360
catcaggcgc cattcgccat tcaggctgcg caactgttgg gaagggcgat cggtgcgggc 6420
ctcttcgcta ttacgccagc tggcgaaagg gggatgtgct gcaaggcgat taagttgggt 6480
aacgccaggg ttttcccagt cacgacgttg taaaacgacg gccagtgaat tcgagctc 6538
<210> 2
<211> 29
<212> DNA
<213> Artificial sequence (LF)
<400> 2
ctcggtacct cagtgataac aaggcctgt 29
<210> 3
<211> 29
<212> DNA
<213> Artificial sequence (LR)
<400> 3
tatgagctcc agtttacttc ctggggttc 29
<210> 4
<211> 63
<212> DNA
<213> Artificial sequence (MF)
<400> 4
ctggagctca taacttcgta tagcatacat tatacgaagt tatataaatg ggtatattgc 60
tcc 63
<210> 5
<211> 63
<212> DNA
<213> Artificial sequence (MR)
<400> 5
taagcatgcg aagttcctat actttctaga gaataggaac ttccaatcaa atcaatcaaa 60
tca 63
<210> 6
<211> 29
<212> DNA
<213> Artificial sequence (SM-F)
<400> 6
ttcgcatgct taagatacat tgatgagtt 29
<210> 7
<211> 63
<212> DNA
<213> Artificial sequence (SM-R)
<400> 7
tatagatctg aagttcctat actttctaga gaataggaac ttctcatcca tccttttcat 60
ccc 63
<210> 8
<211> 63
<212> DNA
<213> Artificial sequence (RF)
<400> 8
ttcagatcta taacttcgta tagcatacat tatacgaagt tattttcata gtaaaagtat 60
gag 63
<210> 9
<211> 29
<212> DNA
<213> Artificial sequence (RR)
<400> 9
caggtcgaca tctcctgtct tcattttta 29
<210> 10
<211> 20
<212> DNA
<213> Artificial sequence (kdrl sgRNA1)
<400> 10
gtaaacagtc tgtgaacccc 20
<210> 11
<211> 20
<212> DNA
<213> Artificial sequence (kdrl sgRNA2)
<400> 11
gtgagagggg tacagtacgg 20
<210> 12
<211> 20
<212> DNA
<213> Artificial sequence (kdrl-LF)
<400> 12
ttggcagggg taaagcacag 20
<210> 13
<211> 20
<212> DNA
<213> Artificial sequence (DsRed-R)
<400> 13
cccacaacga ggactacacc 20
<210> 14
<211> 20
<212> DNA
<213> Artificial sequence (DsRed-F)
<400> 14
cccttggtca ccttcagctt 20
<210> 15
<211> 20
<212> DNA
<213> Artificial sequence (kdrl-RR)
<400> 15
aacgtgccac ttgacatcca 20

Claims (8)

1. A method for researching blood vessel growth by conditionally inducing kdrl gene knockout in zebra fish is characterized by comprising the following steps:
(1) searching two specific recognition sites of nuclease at two ends of the 12 th exon of the zebra fish kdrl, wherein the specific recognition sites are a sgRNA1 target spot and a sgRNA2 target spot;
(2) constructing a non-homologous end-linked knock-in plasmid, wherein the knock-in plasmid contains a left homologous arm sequence and a left homologous arm sequence, the left arm contains one nuclease recognition site sgRNA1, the right arm contains the other nuclease recognition site sgRNA2, a nucleotide sequence of an exogenous gene to be replaced is contained between the left arm and the right arm, and the nucleotide sequence comprises loxP sites on two sides of a 12 th exon and a myocardial cell marker red fluorescent protein for screening; injecting a nuclease system into the fertilized eggs of the zebra fish by microinjection; culturing the injected fertilized eggs into fish, and confirming that the zebra fish is knocked out conditionally by kdrl through fluorescence and genotype identification;
(3) hybridizing a transgenic strain marked with zebra fish vascular endothelial cells with the conditional knockout strain, and obtaining a double-transgenic strain through fluorescence screening;
(4) cre mRNA was injected into embryos generated by the double transgenic introgression described above, and zebrafish embryos were used after 3 days to identify deletion of kdrl, overall phenotypic observation, and phenotypic observation of vascular growth.
2. The method for conditionally inducing kdrl gene knock-out in zebrafish according to claim 1 for studying vascular growth, characterized in that: in step (1), the nucleases are CRIPSR nuclease and Cas9 nuclease.
3. The method for conditionally inducing kdrl gene knock-out in zebrafish according to claim 1 for studying vascular growth, characterized in that: in step (2), the nuclease system includes Cas9 protein or mRNA producing Cas9 protein, sgRNA1 and sgRNA2, kdrl knock-in plasmid.
4. The method for conditionally inducing kdrl gene knock-out in zebrafish according to claim 3 for studying vascular growth, characterized in that: in step (2), the target sequence of sgRNA1 is: gtaaacagtctgtgaacccc, respectively; the target sequence of sgRNA2 is: gtgagaggggtacagtacgg are provided.
5. The method for conditionally inducing kdrl gene knock-out in zebrafish according to claim 4 for studying vascular growth, characterized in that: in the step (2), the nucleotide sequence of the left homology arm is shown as SEQ ID NO:1, and the nucleotide sequence of the right homology arm is shown in SEQ ID NO:1, and the nucleotide sequence of the foreign gene to be replaced between the right arms is shown as SEQ ID NO: 693-2576 in 1.
6. The method for conditionally inducing kdrl gene knock-out in zebrafish according to claim 5 for studying vascular growth, characterized in that: in the step (2), constructing the left homologous arm and the right homologous arm of the knock-in plasmid connected with the non-homologous ends, taking a zebra fish genome as a template, and adding enzyme cutting sites and protective bases into a PCR primer for amplification to obtain the zebra fish genome; a sequence between two loxP sites of the fourth exon is amplified by taking a zebra fish genome as a template and a loxP-kdrl _ exon12-frt fusion sequence through a loxP and frt fusion sequence PCR primer, and the PCR primer is added with a restriction enzyme site and a protective base; the red fluorescent protein sequence can be marked by the screened cardiac muscle cells, the loxP-myl7-DsRed-pA-frt fusion sequence is obtained by amplifying the fusion sequence PCR primer of loxP and frt, and the PCR primer is added with the enzyme cutting site and the protective basic group.
7. The method for conditionally inducing kdrl gene knock-out in zebrafish according to claim 6 for studying vascular growth, characterized in that: in step (2), the donor plasmid was knocked in and zebrafish zygotes were injected and screened for conditional knock-in lines that yielded tcf3 a.
8. The method for conditionally inducing kdrl gene knock-out in zebrafish according to claim 5 for studying vascular growth, characterized in that: in the step (3), the zebra fish product line for marking the vascular endothelial cells utilizes a kdrl promoter to drive the expression of EGFP, and is named as Tg.
CN202010718925.5A 2020-07-23 2020-07-23 Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish Pending CN112111512A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010718925.5A CN112111512A (en) 2020-07-23 2020-07-23 Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010718925.5A CN112111512A (en) 2020-07-23 2020-07-23 Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish

Publications (1)

Publication Number Publication Date
CN112111512A true CN112111512A (en) 2020-12-22

Family

ID=73799724

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010718925.5A Pending CN112111512A (en) 2020-07-23 2020-07-23 Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish

Country Status (1)

Country Link
CN (1) CN112111512A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李燕: "《精编分子生物学实验技术》", 30 September 2017, 世界图书出版公司 *

Similar Documents

Publication Publication Date Title
CN108753813B (en) Method for obtaining marker-free transgenic plants
CN110540989A (en) Primer and method for cloning unknown DNA sequence adjacent to known region based on PCR technology
CN108486105B (en) Kluyveromyces marxianus promoter as well as preparation method and application thereof
CN111171132B (en) Snakehead antibacterial peptide
CN111304252B (en) Method for injecting virus into specific brain region of animal for gene editing based on non-therapeutic purpose of PINK1 and PARK7
CN105176936B (en) Replicate the subclone and preparation method and application of the Semliki forest virus of tolerance type
CN101775410B (en) Fowlpox virus vector shuttle plasmid and application thereof
CN113061626B (en) Method for knocking out zebra fish genes in tissue-specific manner and application
CN101693901B (en) Colibacillus-corynebacterium inducible expression carrier pDXW-8 and building method thereof
CN110734480B (en) Application of Escherichia coli molecular chaperone GroEL/ES in assisting synthesis of plant Rubisco
CN111304245B (en) Method for injecting virus into specific brain region of animal for gene editing based on non-therapeutic purpose of MECP2 gene
KR101578444B1 (en) Recombinant foot-and-mouth disease virus using Korean isolated strain of FMDV A serotype and the manufacturing method
CN108728484B (en) Vector for obtaining marker-free transgenic plant and application thereof
CN111304257B (en) Method for gene editing by injecting virus into specific brain region of animal based on PSEN1 gene for non-therapeutic purpose
CN102241763A (en) Continuously activated growth hormone receptor gene of fishes, and preparation method and application thereof
CN114438083A (en) sgRNA for identifying pig PERV gene and coding DNA and application thereof
CN112111512A (en) Method for researching blood vessel growth by conditional induction kdrl gene knockout in zebra fish
CN108410870B (en) Kluyveromyces marxianus promoter, secretion signal peptide, preparation and application thereof
CN106520837A (en) Recombinant vector and application thereof
CN110157721A (en) A kind of tracer target practice plasmid of vaccinia virus Tiantan strain and preparation method thereof
CN110305873A (en) Editor&#39;s label ben-1sgRNA target site and its CRISPR/Cas9 are total to editing system and application altogether
CN114317605B (en) Construction method of microglial cell potassium ion probe transgenic mouse model
CN104450768B (en) A kind of shuttle vector for targeting yeast mitochondrial and its application
CN110747216A (en) Multigene co-expression complete vector and application thereof
CN104673832B (en) A method of assembling TALE/TALEN module

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination